Case Reports
doi: 10.1097/YCT.0b013e3181926ada.
Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report
Affiliations
- PMID: 19190508
- DOI: 10.1097/YCT.0b013e3181926ada
Item in Clipboard
Case Reports
Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report
J ECT.
2009 Sep.
Abstract
Cognitive deficits are commonly associated with maintenance electroconvulsive therapy (ECT). Treatment of these cognitive deficits is important but difficult. Cholinergic pathways are involved in these side effects, and donepezil, a cholinesterase inhibitor, may be useful for improvement of cognition. In this case report, we describe for the first time successful use of donepezil in treating cognitive deficits associated with maintenance ECT. The role of cholinesterase inhibitors in the treatment of cognitive deficits caused by ECT needs further studies.
Similar articles
-
Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial.J ECT. 2006 Sep;22(3):163-8. doi: 10.1097/01.yct.0000230365.81368.2d. J ECT. 2006. PMID: 16957530 Clinical Trial.
-
Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?J Fam Pract. 2006 May;55(5):435-6. J Fam Pract. 2006. PMID: 16670040 Review. No abstract available.
-
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.Int J Geriatr Psychiatry. 2004 Jan;19(1):1-8. doi: 10.1002/gps.993. Int J Geriatr Psychiatry. 2004. PMID: 14716693 Clinical Trial.
-
A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.Hum Psychopharmacol. 2005 Apr;20(3):183-7. doi: 10.1002/hup.676. Hum Psychopharmacol. 2005. PMID: 15700322 Review.
-
A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.J Psychopharmacol. 2007 Jun;21(4):421-7. doi: 10.1177/0269881106070996. Epub 2006 Nov 8. J Psychopharmacol. 2007. PMID: 17092979 Clinical Trial.
Cited by
-
Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.J ECT. 2020 Mar;36(1):42-46. doi: 10.1097/YCT.0000000000000613. J ECT. 2020. PMID: 31192873 Free PMC article.
-
Medication management during electroconvulsant therapy.Neuropsychiatr Dis Treat. 2016 Apr 19;12:931-9. doi: 10.2147/NDT.S100908. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27143894 Free PMC article.
-
Therapeutic and prophylactic role of cognitive enhancers in electroconvulsive therapy-induced cognitive deficits.Ind Psychiatry J. 2019 Jul-Dec;28(2):286-293. doi: 10.4103/ipj.ipj_105_20. Epub 2020 Aug 14. Ind Psychiatry J. 2019. PMID: 33223724 Free PMC article.
-
Pathogenetic and therapeutic perspectives on neurocognitive models in psychiatry: A synthesis of behavioral, brain imaging, and biological studies.Indian J Psychiatry. 2012 Jul;54(3):217-22. doi: 10.4103/0019-5545.102410. Indian J Psychiatry. 2012. PMID: 23226843 Free PMC article.
-
Efficacy of memoral herbal on prevention of electroconvulsive therapy-induced memory impairment in mood disorder patients (isfahan - iran 2011).Int J Prev Med. 2012 Jul;3(7):499-503. Int J Prev Med. 2012. PMID: 22891152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
